Manchester Financial’s BioSpecifics Technologies Corp. BSTC Stock Holding History

Manchester Financial’s Portfolio BSTC Stock Details BSTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-2,954	Closed	-$156K	–	677
2020 Q3	$156K	Buy	2,954 +300	+11%	+$18.5K	0.12%	61
2020 Q2	$163K	Buy	2,654 +50	+2%	+$2.89K	0.13%	61
2020 Q1	$147K	Sell	2,604 -3,510	-57%	-$200K	0.11%	70
2019 Q4	$348K	Hold	6,114	–	–	0.14%	42
2019 Q3	$327K	Hold	6,114	–	–	0.14%	41
2019 Q2	$365K	Sell	6,114 -200	-3%	-$12.6K	0.16%	38
2019 Q1	$394K	Hold	6,314	–	–	0.19%	37
2018 Q4	$383K	Buy	+6,314	New	+$377K	0.21%	39

Other funds holding BSTC

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Manchester Financial's BSTC Position: Q4 2020 in Review

Manchester Financial sold out of BioSpecifics Technologies Corp. (BSTC) in Q4 2020, closing a stake of 2,954 shares — an estimated $156K sold.

Manchester Financial first reported a position in BSTC in Q4 2018 and held it in 8 quarters. The position peaked at $394K in Q1 2019. 1 fund tracked by Wall St. Rank holds BSTC as of Q4 2020.

Manchester Financial reported no remaining BioSpecifics Technologies Corp. position as of Q4 2020 after selling out during the quarter.
Manchester Financial sold 2,954 BioSpecifics Technologies Corp. shares in Q4 2020, an estimated $156K.
Manchester Financial first reported a position in BioSpecifics Technologies Corp. in Q4 2018 and held it in 8 quarters.
Manchester Financial's BioSpecifics Technologies Corp. position peaked at $394K in Q1 2019.
1 fund tracked by Wall St. Rank held BioSpecifics Technologies Corp. as of Q4 2020.

Based on Manchester Financial's 13F filing for Q4 2020, filed 26 Jan 2021.